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ABSTRACT
 
Neuroendocrine tumours of the pancreas can have a spectrum of behaviour from relatively
benign to aggressive. Resection can result in cure although metastatic disease is described.
We present an unusual case of an apparent local recurrence of previously resected
neuroendocrine tumour in a young man who had undergone distal pancreatectomy.
Pathological analysis demonstrated focal post-surgical pancreatitis with radiological
appearances bearing striking similarity to the original primary tumour.
INTRODUCTION
Neuroendocrine tumours of the pancreas have previously presented in association with both
acute and chronic pancreatitis (1,2,3). By contrast pancreatitis presenting as a malignant
neuroendocrine tumour has never been reported.
We report a case of post-surgical pancreatitis presenting clinically as recurrent neuroendocrine
tumour of the pancreas.
CASE REPORT
A 42 year old man presented with a history of flushing and sweats and was found on
investigation to have a lesion associated with the body of his pancreas. His gut hormone profile
was normal and urinary 5-hydroxy indole acetic acid levels were similarly within the normal
range. He underwent biopsy of the lesion via endoscopic ultrasound which confirmed the
presence of a neuroendocrine tumour of carcinoid subtype. He underwent a spleen preserving
distal pancreatectomy for a carcinoid tumour situated in the midbody of the pancreas (fig1).
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At operation this was a well defined lesion with no evidence of intra-abdominal metastasis.
There was no evidence of pancreatitis and the remaining gland appeared normal. Pathology
confirmed a single well demarcated mass that histologically was a well-differentiated endocrine
tumour. No lymphovascular space invasion was noted and complete excision was achieved
with good margins. The tumour measured 39mm, the Ki-67 proliferation index was less than
2% and together with a mitotic count of less than 1 in 10 high powered fields confirmed this
was, according to the WHO classification, a well-differentiated (grade 1) endocrine tumour of
uncertain behaviour. No cytological atypia or necrosis was identified. The patient made an
uneventful post operative recovery however at follow up 6 months later he complained of
recurrent sweats and hot flushes. CT scan showed apparent evidence of recurrence of tumour
at the site of the previous resection margin in a similar location to the original primary tumour
with additional abnormal soft tissue adjacent to the greater curvature of the stomach consistent
with local or nodal recurrence. No liver or lung metastases were identified. These findings were
confirmed on MRI scan (fig 2).
Laparotomy was performed which showed what appeared to be recurrent tumour at the
anterior aspect of the pancreas infiltrating through the posterior wall of the stomach over a
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significant surface area with additional tumour deposits in the transverse mesocolon. A
subtotal gastrectomy with Roux-en-Y reconstruction, transverse colectomy, resection of body
of pancreas and splenectomy were carried out. The patient made a good recovery.
Subsequent pathology showed similar macroscopic and microscopic features for all the lesions
described. These were necrotic pseudocystic structures encased within inflamed fibrous tissue.
There was surrounding fat necrosis, giant cell reaction and haemosiderin-laden macrophages
were prominent. The inflammation expanded to involve the wall of stomach explaining the
intraoperative appearance. These findings were consistent with subclinical post-surgical
pancreatitis. No histological evidence of a residual endocrine neoplasm or other malignancy
was identified.
DISCUSSION 
Malignant non functioning neuroendocrine tumours of the pancreas are uncommon. They
often present late with weight loss and abdominal pain being their most common clinical
manifestations (4,5). Their prognosis is considerably better than for adenocarcinoma of the
pancreas. Resection is the treatment of choice. A negative resection margins is a favourable
prognostic indicator (5,6,7) however, recurrence following curative resection has been
reported to be as high as 20% (8). Other factors indicating a favourable outcome include small
tumour size, absence of lymph node invasion and distant metastases.
Various pancreatic masses have in the past been reported as mimicking pancreatic cancer
with radiological studies not always successful in differentiating the aetiology of a pancreatic
mass (9). In addition both chronic pancreatitis and peripancreatic fat necrosis following
acute pancreatitis have been misdiagnosed as pancreatic malignancies both on clinical and
radiological findings with the correct diagnosis only confirmed on surgical pathology or
percutaneous biopsy with prolonged follow up showing no evidence of malignancy (10,11,12
). Reports have suggested that 18F-fluordeoxyglucose scanning is a highly sensitive and
specific method to differentiate between benign and malignant masses including
neuroendocrine tumours (13). It would also have been possible to use either radionucleotide
Octreotide or Meta-iodobenzylguanidine (MIBG) scanning to try and improve the accuracy of
diagnosis of neuroendocrine carcinoma. These receptor ligand assays can be very useful in a
diagnostic setting but are not always positive in patients with neuroendocrine cancer.
This patient’s initial presenting symptoms were flushing and night sweats despite never having
any liver metastases. In addition gut hormone and 5HIAA levels were normal. It was
recurrence of these symptoms post operatively which prompted further investigations.
It was unusual that this patient’s neuroendocrine tumour appeared to have recurred so
aggressively and so promptly following resection. This is particularly so since the primary
tumour had been a circumscribed well-differentiated endocrine neoplasm excised with a
clearance of 7.5mm.  However, the CT and MRI results were so compelling for tumour
recurrence that tumour recurrence could not be excluded and certainly at operation the tissue
characteristics were classical of tumour deposits.
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Prior to his initial surgery he had never had elevated 5HIAA urinary levels and therefore this
was not a useful marker to assess possible recurrence.
Laparoscopy would have been of no benefit in characterising the lesions and with significant
necrotic tissue and a severe inflammatory reaction it would have been  difficult to differentiate
on frozen section.
With such convincing findings both on imaging and at surgery the diagnosis could only be
made with any reassurance following resection.
REFERENCES
1. Shiota K, Jimi A, Yamaguchi R, Hara M, Kinoshita H, KojiroM. Carcinoid tumour of the
Vater’s papilla presenting with chronic pancreatitis – a case report. Kurume Med J.
2005;52(3):105-9
2. Shrikhande S, KleeffJ, ZimmermannA, Friess H, Buchler MW. Co-existent chronic
pancreatitis and pancreatic neuroendocrine tumour. Case report and review of the
literature. Pancreatology. 2001;1(2):117-22
3. Jukemura J, Montagnini AL, Perini MV, deAlmeida JL, RodriguesJJ, da Cunha JE. Acute
pancreatitis associated with neuroendocrine tumor of the pancreas. JOP.2006
11;7(1):56-61
4. Han JH, Kim MH, Moon SH, Park SJ, Park do H, Lee SS, Seo DW, Lee SK, Kim SC, Han
DJ. Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine
tumours. Korean J Gastroenterol. 2009;53(2):98-105
5. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL. Surgical experience
with pancreatic and peripancreatic neuroendocrine tumours: review of 125 patients. J
Gastrointest Surg. 1998;2(5):472-82
6. Chung JC, Choi DW, Jo SH, Heo JS, Choi SH, Kim YI. Malignant non-functioning
endocrine tumors of the pancreas: predictive factors for survival after surgical treatment.
World J Surg. 2007;31(3):578-85
7. Bahra M, Jacob D, Pascher A, Plockinger U, Kristiansen G. Surgical strategies and
predictors of outcome for malignant neuroendocrine tumours of the pancreas. Journal of
Gastroenterology and Hepatology 2007; 22 930-935
8. Nguyen SQ, Angel LP, Divino CM, Schluender S, Warner RR. Surgery in malignant
pancreatic neuroendocrine tumors. J Surg Oncol. 2007 Oct 1;96(5):397-403
9. Semelka RC, Ascher SM. MR imaging of the pancreas. Radiology 1993; 188:593-602
10. Toosi MN, Heathcote J. Pancreatic pseudotumour with sclerosing pancreato-cholangitis:
is this a systemic disease? Am J Gastroenterol. 2004; 99(2):377-82
11. Patlas M, Deitel W, taylor B, Gallinger S, Wilson SR. Focal chronic pancreatitis mimicking
pancreatic head carcinoma: are there suggestive features of ultrasound? Can Assoc
Radiol J. 2007 ;58(1):15-21
12. Thurnher MM, Schima W, Turerschek K, Thurnher SA, Fugger R, Oberhuber G.
Peripancreatic fat necrosis mimicking pancreatic cancer. Eur. Radiol. 2001; 11: 922-925
13. Singer E, Gschwantler M, Plattner D, Kriwanek S, Armbruster C, Schueller J, Feichtinger
H, Roka R, Moeschi P, Weiss W, Kroiss A. Differential diagnosis of benign and malignant
page 4 / 5
JSCR
Journal of Surgical Case Reports
http://jscr.co.uk
pancreatic masses with 18F-fluordeoyglucose-positron emission tomography recorded
with a dual-head coincidence gamma camera. Eur J Gastroenterol Hepatol.
2007:19(6):471-8
Powered by TCPDF (www.tcpdf.org)
page 5 / 5
